Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild-to-moderate renal impairment

  1. Javier Escalada, F.
  2. Halimi, S.
  3. Senior, P.A.
  4. Bonnemaire, M.
  5. Cali, A.M.G.
  6. Melas-Melt, L.
  7. Karalliedde, J.
  8. Ritzel, R.A.
Aldizkaria:
Diabetes, Obesity and Metabolism

ISSN: 1463-1326,  1462-8902

Argitalpen urtea: 2018

Alea: 20

Zenbakia: 12

Orrialdeak: 2860-2868

Mota: Artikulua

DOI: 10.1111/DOM.13470 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus